I think it's more accurate to say that NGS is still in the midst of disrupting biology in general. Illumina has been consistently dropping sequencing prices for

I think it's more accurate to say that NGS is still in the midst of disrupting biology in general. Illumina has been consistently dropping sequencing prices for the last 7 years. Oxford Nanopore is a very promising technology as well that could completely disrupt the space. I wouldn't say the the industry is ripe to be disrupted by software though. The cheapness of sequencing enables the development of new software for analysis, which in turn enables more sequencing.